Endocrine disrupting chemicals targeting estrogen receptor signaling: Identification and mechanisms of action

Chemical Research in Toxicology

Volumn 24, Issue 1, 2011, Pages 6-19

  Shanle, Erin K ^b   Xu, Wei ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; AROMATIC HYDROCARBON RECEPTOR; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; ORGANOCHLORINE PESTICIDE; PHENOL DERIVATIVE; PHYTOESTROGEN; TRANSCRIPTION FACTOR;

DNA BINDING; ENZYME MODIFICATION; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; GENE CONTROL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; REVIEW;

ENDOCRINE DISRUPTORS; HYDROCARBONS, CHLORINATED; PHENOLS; PHYTOESTROGENS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 78651482291     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx100231n     Document Type: Review

References (154)

1. Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., and Gore, A. C. (2009) Endocrine-disrupting chemicals: An Endocrine Society scientific statement Endocr. Rev. 30, 293-342
2. Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J. A. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta Endocrinology 138, 863-870 (Pubitemid 27089735)
3. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J. A. (1996) Cloning of a novel receptor expressed in rat prostate and ovary Proc. Natl. Acad. Sci. U.S.A. 93, 5925-5930
4. Enmark, E., Pelto-Huikko, M., Grandien, K., Lagercrantz, S., Lagercrantz, J., Fried, G., Nordenskjold, M., and Gustafsson, J. A. (1997) Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern J. Clin. Endocrinol. Metab. 82, 4258-4265
5. Taylor, A. H. and Al-Azzawi, F. (2000) Immunolocalisation of oestrogen receptor beta in human tissues J. Mol. Endocrinol. 24, 145-155
6. Hewitt, S. C., Harrell, J. C., and Korach, K. S. (2005) Lessons in estrogen biology from knockout and transgenic animals Annu. Rev. Physiol. 67, 285-308
7. Harris, H. A. (2007) Estrogen receptor-beta: Recent lessons from in vivo studies Mol. Endocrinol. 21, 1-13
8. Paruthiyil, S., Parmar, H., Kerekatte, V., Cunha, G. R., Firestone, G. L., and Leitman, D. C. (2004) Estrogen receptor β inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest Cancer Res. 64, 423-428
9. Murphy, L. C., Peng, B., Lewis, A., Davie, J. R., Leygue, E., Kemp, A., Ung, K., Vendetti, M., and Shiu, R. (2005) Inducible upregulation of oestrogen receptor-β1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells J. Mol. Endocrinol. 34, 553-566
10. Ström, A., Hartman, J., Foster, J. S., Kietz, S., Wimalasena, J., and Gustafsson, J. A. (2004) Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D Proc. Natl. Acad. Sci. U.S.A. 101, 1566-1571
11. Sotoca, A. M., van den Berg, H., Vervoort, J., van der Saag, P., Strom, A., Gustafsson, J. A., Rietjens, I., and Murk, A. J. (2008) Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells Toxicol. Sci. 105, 303-311
12. Shanle, E. K. and Xu, W. (2010) Selectively targeting estrogen receptors for cancer treatment, Adv. Drug Delivery Rev. [online early access], DOI: 10.1016/j.addr.2010.08.001, published online Aug 10, 2010.
13. Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Strom, A., Treuter, E., Warner, M., and Gustafsson, J. A. (2007) Estrogen receptors: How do they signal and what are their targets Physiol. Rev. 87, 905-931
14. Cowley, S. M. and Parker, M. G. (1999) A comparison of transcriptional activation by ERα and ERβ J. Steroid Biochem. Mol. Biol. 69, 165-175
15. Zwart, W., de Leeuw, R., Rondaij, M., Neefjes, J., Mancini, M. A., and Michalides, R. (2010) The hinge region of the human estrogen receptor determines functional synergy between AF-1 and AF-2 in the quantitative response to estradiol and tamoxifen J. Cell Sci. 123, 1253-1261
16. Lin, C.-Y., Vega, V. B., Thomsen, J. S., Zhang, T., Kong, S. L., Xie, M., Chiu, K. P., Lipovich, L., Barnett, D. H., Stossi, F., Yeo, A., George, J., Kuznetsov, V. A., Lee, Y. K., Charn, T. H., Palanisamy, N., Miller, L. D., Cheung, E., Katzenellenbogen, B. S., Ruan, Y., Bourque, G., Wei, C.-L., and Liu, E. T. (2007) Whole-genome cartography of estrogen receptor α binding sites PLoS Genet 3 e87
17. Carroll, J. S., Meyer, C. A., Song, J., Li, W., Geistlinger, T. R., Eeckhoute, J., Brodsky, A. S., Keeton, E. K., Fertuck, K. C., Hall, G. F., Wang, Q., Bekiranov, S., Sementchenko, V., Fox, E. A., Silver, P. A., Gingeras, T. R., Liu, X. S., and Brown, M. (2006) Genome-wide analysis of estrogen receptor binding sites Nat. Genet. 38, 1289
18. Liu, Y., Gao, H., Marstrand, T. T., Ström, A., Valen, E., Sandelin, A., Gustafsson, J.-Ã. k., and Dahlman-Wright, K. (2008) The genome landscape of ERα-and ERβ-binding DNA regions Proc. Natl. Acad. Sci. U.S.A. 105, 2604-2609
19. Zhao, C., Gao, H., Liu, Y., Papoutsi, Z., Jaffrey, S., Gustafsson, J.-Ã. k., and Dahlman-Wright, K. (2010) Genome-wide mapping of estrogen receptor-β binding regions reveals extensive cross-talk with transcription factor activator protein-1 Cancer Res. 70, 5174-5183
20. Secreto, F. J., Monroe, D. G., Dutta, S., Ingle, J. N., and Spelsberg, T. C. (2007) Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells J. Cell. Biochem. 101, 1125-1147
21. Monroe, D., Barbara, J. G., Steven, A. J., Riggs, B. L., Sundeep, K., and Thomas, C. S. (2003) Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta J. Cell. Biochem. 90, 315-326
22. Pettersson, K., Grandien, K., Kuiper, G. G., and Gustafsson, J. A. (1997) Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha Mol. Endocrinol. 11, 1486-1496
23. Powell, E. and Xu, W. (2008) Intermolecular interactions identify ligand-selective activity of estrogen receptor α/β dimers Proc. Natl. Acad. Sci. U.S.A. 105, 19012-19017
24. Kushner, P. J., Agard, D. A., Greene, G. L., Scanlan, T. S., Shiau, A. K., Uht, R. M., and Webb, P. (2000) Estrogen receptor pathways to AP-1 J. Steroid Biochem. Mol. Biol. 74, 311-317
25. Saville, B., Wormke, M., Wang, F., Nguyen, T., Enmark, E., Kuiper, G., Gustafsson, J. A., and Safe, S. (2000) Ligand-, cell-, and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements J. Biol. Chem. 275, 5379-5387
26. Brzozowski, A. M., Pike, A. C., Dauter, Z., Hubbard, R. E., Bonn, T., Engstrom, O., Ohman, L., Greene, G. L., Gustafsson, J. A., and Carlquist, M. (1997) Molecular basis of agonism and antagonism in the oestrogen receptor Nature 389, 753-758
27. Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., and Greene, G. L. (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen Cell 95, 927-937
28. Pike, A. C., Brzozowski, A. M., Hubbard, R. E., Bonn, T., Thorsell, A. G., Engstrom, O., Ljunggren, J., Gustafsson, J., and Carlquist, M. (1999) Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist EMBO J. 18, 4608-4618
29. Lonard, D. M. and O'Malley, B. W. (2007) Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation Mol. Cell 27, 691-700
30. Bjornstrom, L. and Sjoberg, M. (2005) Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes Mol. Endocrinol. 19, 833-842
31. Filardo, E. J., Quinn, J. A., Bland, K. I., and Frackelton, A. R., Jr. (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF Mol. Endocrinol. 14, 1649-1660
32. Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., and Auricchio, F. (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells EMBO J. 15, 1292-1300
33. Chen, Z., Yuhanna, I. S., Galcheva-Gargova, Z., Karas, R. H., Mendelsohn, M. E., and Shaul, P. W. (1999) Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen J. Clin. Invest. 103, 401-406 (Pubitemid 29069990)
34. Improta-Brears, T., Whorton, A. R., Codazzi, F., York, J. D., Meyer, T., and McDonnell, D. P. (1999) Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium Proc. Natl. Acad. Sci. U.S.A. 96, 4686-4691
35. Aronica, S. M., Kraus, W. L., and Katzenellenbogen, B. S. (1994) Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription Proc. Natl. Acad. Sci. U.S.A. 91, 8517-8521
36. Nadal, A., Ropero, A. B., Laribi, O., Maillet, M., Fuentes, E., and Soria, B. (2000) Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor α and estrogen receptor β Proc. Natl. Acad. Sci. U.S.A. 97, 11603-11608
37. Safe, S. and Kim, K. (2008) Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways J. Mol. Endocrinol. 41, 263-275
38. Wu, F., Khan, S., Wu, Q., Barhoumi, R., Burghardt, R., and Safe, S. (2008) Ligand structure-dependent activation of estrogen receptor [alpha]/Sp by estrogens and xenoestrogens J. Steroid Biochem. Mol. Biol. 110, 104-115
39. Chadwick, C. C., Chippari, S., Matelan, E., Borges-Marcucci, L., Eckert, A. M., Keith, J. C., Albert, L. M., Leathurby, Y., Harris, H. A., Bhat, R. A., Ashwell, M., Trybulski, E., Winneker, R. C., Adelman, S. J., Steffan, R. J., and Harnish, D. C. (2005) Identification of pathway-selective estrogen receptor ligands that inhibit NFκB transcriptional activity Proc. Natl. Acad. Sci. U.S.A. 102, 2543-2548
40. Kalaitzidis, D. and Gilmore, T. D. (2005) Transcription factor cross-talk: the estrogen receptor and NF-[kappa]B Trends Endocrinol. Metab. 16, 46-52
41. Swaby, R., Sharma, C., and Jordan, V. (2007) SERMs for the treatment and prevention of breast cancer Rev. Endocr. Metab. Disord. 8, 229-239
42. Shang, Y. and Brown, M. (2002) Molecular determinants for the tissue specificity of SERMs Science 295, 2465-2468
43. Wu, F. and Safe, S. (2007) Differential activation of wild-type estrogen receptor [alpha] and C-terminal deletion mutants by estrogens, antiestrogens and xenoestrogens in breast cancer cells J. Steroid Biochem. Mol. Biol. 103, 1-9
44. Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., and Gustafsson, J. A. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β Endocrinology 139, 4252-4263
45. Minutolo, F., Macchia, M., Katzenellenbogen, B. S., and Katzenellenbogen, J. A. (2009) Estrogen receptor beta ligands: Recent advances and biomedical applications, Med. Res. Rev. [online early access], DOI: 10.1002/med.20186, published online Dec 4, 2009.
46. Kortenkamp, A. (2007) Ten years of mixing cocktails: A review of combination effects of endocrine-disrupting chemicals Environ. Health Perspect. 115
47. Swedenborg, E., Ruegg, J., Makela, S., and Pongratz, I. (2009) Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders J. Mol. Endocrinol. 43, 1-10
48. le Maire, A., Bourguet, W., and Balaguer, P. (2010) A structural view of nuclear hormone receptor: endocrine disruptor interactions Cell. Mol. Life Sci. 67, 1219
49. Herbst, A. L., Cole, P., Colton, T., Robboy, S. J., and Scully, R. E. (1977) Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix Am. J. Obstet. Gynecol. 128, 43-50
50. Giusti, R. M., Iwamoto, K., and Hatch, E. E. (1995) Diethylstilbestrol revisited: A review of the long-term health effects Ann. Intern. Med. 122, 778-788
51. Newbold, R. R., Padilla-Banks, E., and Jefferson, W. N. (2006) Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations Endocrinology 147 s11-17
52. Bredfeldt, T. G., Greathouse, K. L., Safe, S. H., Hung, M.-C., Bedford, M. T., and Walker, C. L. (2010) Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signaling to PI3K/AKT Mol. Endocrinol. 24, 993-1006
53. Tiemann, U. (2008) In vivo and in vitro effects of the organochlorine pesticides DDT, TCPM, methoxychlor, and lindane on the female reproductive tract of mammals: A review Reprod. Toxicol. 25, 316
54. Turusov, V., Rakitsky, V., and Tomatis, L. (2002) Dichlorodiphenyltrichloroethane (DDT): Ubiquity, persistence, and risks Environ. Health Perspect. 110
55. U.S. Environmental Protection Agency (2004) Methoxychlor Reregistration Eligibility Decision (RED), EPA Publication No. EPA 738-R-04-010, June 30.
56. Cummings, A. M. (1997) Methoxychlor as a Model for Environmental Estrogens Crit. Rev. Toxicol. 27, 367-379
57. Gaido, K. W., Leonard, L. S., Maness, S. C., Hall, J. M., McDonnell, D. P., Saville, B., and Safe, S. (1999) Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors {alpha} and {beta} Endocrinology 140, 5746-5753
58. Gaido, K. W., Maness, S. C., McDonnell, D. P., Dehal, S. S., Kupfer, D., and Safe, S. (2000) Interaction of methoxychlor and related compounds with estrogen receptor α and β, and androgen receptor: structure-activity studies Mol. Pharmacol. 58, 852-858
59. Hewitt, S. C. and Korach, K. S. (2010) Estrogenic activity of bisphenol A and 2,2-bis(p -hydroxyphenyl)-1,1-1-trichloroethane (HPTE) demonstrated in mouse uterine gene profiles. Environ. Health Perspect., published online Sep 8, 2010.
60. Calafat, A. M., Ye, X., Wong, L.-Y., Reidy, J. A., and Needham, L. L. (2007) Exposure of the U.S. population to bisphenol A and 4-tertiary- octylphenol: 2003-2004 Environ. Health Perspect. 116, 39-44
61. Vandenberg, L. N., Maffini, M. V., Sonnenschein, C., Rubin, B. S., and Soto, A. M. (2009) Bisphenol-A and the great divide: A review of controversies in the field of endocrine disruption Endocr. Rev. 30, 75-95
62. Paris, F., Balaguer, P., Térouanne, B., Servant, N., Lacoste, C., Cravedi, J.-P., Nicolas, J.-C., and Sultan, C. (2002) Phenylphenols, biphenols, bisphenol-A and 4-tert-octylphenol exhibit [alpha] and [beta] estrogen activities and antiandrogen activity in reporter cell lines Mol. Cell. Endocrin. 193, 43-49
63. Markey, C. M., Michaelson, C. L., Veson, E. C., Sonnenschein, C., and Soto, A. M. (2001) The mouse uterotrophic assay: A reevaluation of its validity in assessing the estrogenicity of bisphenol A Environ. Health Perspect. 109, 55
64. Watson, C. S., Bulayeva, N. N., Wozniak, A. L., and Finnerty, C. C. (2005) Signaling from the membrane via membrane estrogen receptor-[alpha]: Estrogens, xenoestrogens, and phytoestrogens Steroids 70, 364-371
65. Thomas, P. and Dong, J. (2006) Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: A potential novel mechanism of endocrine disruption J. Steroid Biochem. Mol. Biol. 102, 175-179
66. Li, X., Zhang, S., and Safe, S. (2006) Activation of kinase pathways in MCF-7 cells by 17[beta]-estradiol and structurally diverse estrogenic compounds J. Steroid Biochem. Mol. Biol. 98, 122-132
67. Routledge, E. J., White, R., Parker, M. G., and Sumpter, J. P. (2000) Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) α and ERβ J. Biol. Chem. 275, 35986-35993
68. White, R., Jobling, S., Hoare, S. A., Sumpter, J. P., and Parker, M. G. (1994) Environmentally persistent alkylphenolic compounds are estrogenic Endocrinology 135, 175-182
69. Terasaka, S., Inoue, A., Tanji, M., and Kiyama, R. (2006) Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis-and benzoylphenols for evaluation of estrogenic activity Toxicol. Lett. 163, 130
70. 6/F10 Somatomammotropes Environ. Health Perspect. 117, 723-730
71. Kuhnle, G. G. C., Dell'Aquila, C., Aspinall, S. M., Runswick, S. A., Mulligan, A. A., and Bingham, S. A. (2008) Phytoestrogen content of beverages, nuts, seeds, and oils J. Agric. Food Chem. 56, 7311-7315
72. Mense, S. M., Hei, T. K., Ganju, R. K., and Bhat, H. K. (2008) Phytoestrogens and breast cancer prevention: Possible mechanisms of action Environ. Health Perspect. 116, 426
73. Strom, S. S., Yamamura, Y., Duphorne, C. M., Spitz, M. R., Babaian, R. J., Pillow, P. C., and Hursting, S. D. (1999) Phytoestrogen intake and prostate cancer: A case-control study using a new database Nutr. Cancer 33, 20-25
74. de Kleijn, M. J. J., van der Schouw, Y. T., Wilson, P. W. F., Adlercreutz, H., Mazur, W., Grobbee, D. E., and Jacques, P. F. (2001) Intake of dietary phytoestrogens is low in postmenopausal women in the United States: The Framingham study 1-4 J. Nutr. 131, 1826-1832
75. Cassidy, A., Brown, J. E., Hawdon, A., Faughnan, M. S., King, L. J., Millward, J., Zimmer-Nechemias, L., Wolfe, B., and Setchell, K. D. R. (2006) Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods J. Nutr. 136, 45-51
76. Kumar, N. B., Cantor, A., Allen, K., Riccardi, D., and Cox, C. E. (2002) The specific role of isoflavones on estrogen metabolism in premenopausal women Cancer 94, 1166
77. Cao, Y., Calafat, A. M., Doerge, D. R., Umbach, D. M., Bernbaum, J. C., Twaddle, N. C., Ye, X., and Rogan, W. J. (2008) Isoflavones in urine, saliva, and blood of infants: data from a pilot study on the estrogenic activity of soy formula J. Exp. Sci. Environ. Epidemiol. 19, 223-234
78. Penza, M., Montani, C., Romani, A., Vignolini, P., Ciana, P., Maggi, A., Pampaloni, B., Caimi, L., and Di Lorenzo, D. (2007) Genistein accumulates in body depots and is mobilized during fasting, reaching estrogenic levels in serum that counter the hormonal actions of estradiol and organochlorines Toxicol. Sci. 97, 299-307
79. Mersereau, J. E., Levy, N., Staub, R. E., Baggett, S., Zogric, T., Chow, S., Ricke, W. A., Tagliaferri, M., Cohen, I., Bjeldanes, L. F., and Leitman, D. C. (2008) Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist Mol. Cell. Endocrinol. 283, 49-57
80. Escande, A., Pillon, A., Servant, N., Cravedi, J.-P., Larrea, F., Muhn, P., Nicolas, J.-C., Cavaillès, V., and Balaguer, P. (2006) Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta Biochem. Pharmacol. 71, 1459
81. Manas, E. S., Xu, Z. B., Unwalla, R. J., and Somers, W. S. (2004) Understanding the selectivity of genistein for human estrogen receptor-[beta] using X-ray crystallography and computational methods Structure 12, 2197-2207
82. An, J., Tzagarakis-Foster, C., Scharschmidt, T. C., Lomri, N., and Leitman, D. C. (2001) Estrogen receptor β-selective transcriptional activity and recruitment of coregulators by phytoestrogens J. Biol. Chem. 276, 17808-17814
83. Nguyen, L. P. and Bradfield, C. A. (2007) The search for endogenous activators of the aryl hydrocarbon receptor Chem. Res. Toxicol. 21, 102
84. Beischlag, T., Morales, J. L., Hollingshead, B., and Perdew, G. (2008) The aryl hydrocarbon receptor complex and the control of gene expression Crit. Rev. Eukaryot. Gene Expr. 18, 207-250
85. Safe, S. and Wormke, M. (2003) Inhibitory aryl hydrocarbon receptor α estrogen receptor β cross-talk and mechanisms of action Chem. Res. Toxicol. 16, 807
86. Burbach, K. M., Poland, A., and Bradfield, C. A. (1992) Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor Proc. Natl. Acad. Sci. U.S.A. 89, 8185-8189
87. Perdew, G. H. (1988) Association of the Ah receptor with the 90-kDa heat shock protein J. Biol. Chem. 263, 13802-13805
88. Wilhelmsson, A., Cuthill, S., Denis, M., Wikström, A. C., Gustafsson, J., and Poellinger, L. (1990) The specific DNA binding activity of the dioxin receptor is modulated by the 90 kd heat shock protein EMBO J. 9, 69-76
89. Kazlauskas, A., Poellinger, L., and Pongratz, I. (1999) Evidence That the Co-chaperone p23 regulates ligand responsiveness of the dioxin (aryl hydrocarbon) receptor J. Biol. Chem. 274, 13519-13524
90. Knoblauch, R. and Garabedian, M. J. (1999) Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction Mol. Cell. Biol. 19, 3748-3759
91. Reyes, H., Reisz-Porszasz, S., and Hankinson, O. (1992) Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor Science 256, 1193-1195
92. Hankinson, O. (2005) Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor Arch. Biochem. Biophys. 433, 379
93. Whitlock, J. P. (2003) Induction of cytochrome P4501A1 Annu. Rev. Pharmacol. Toxicol. 39, 103
94. Ohtake, F., Takeyama, K.-i., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., Yanagisawa, J., Fujii-Kuriyama, Y., and Kato, S. (2003) Modulation of oestrogen receptor signalling by association with the activated dioxin receptor Nature 423, 545
95. Shipley, J. M. and Waxman, D. J. (2006) Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methycholanthrene Toxicol. Appl. Pharmacol. 213, 87
96. Safe, S., Astroff, B., Harris, M., Zacharewski, T., Dickerson, R., Romkes, M., and Biegel, L. (1991) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antioestrogens: Characterization and mechanism of action Pharmacol. Toxicol. 69, 400-409
97. Astroff, B., Rowlands, C., Dickerson, R., and Safe, S. (1990) 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibition of 17 beta-estradiol-induced increases in rat uterine epidermal growth factor receptor binding activity and gene expression Mol. Cell. Endocrinol. 72, 247-252
98. Zacharewski, T. R., Bondy, K. L., McDonell, P., and Wu, Z. F. (1994) Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression Cancer Res. 54, 2707-2713
99. DuSell, C. D., Nelson, E. R., Wittmann, B. M., Fretz, J. A., Kazmin, D., Thomas, R. S., Pike, J. W., and McDonnell, D. P. (2010) Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators Mol. Endocrinol. 24, 33-46
100. Amakura, Y., Tsutsumi, T., Nakamura, M., Kitagawa, H., Fujino, J., Sasaki, K., Toyoda, M., Yoshida, T., and Maitani, T. (2003) Activation of the aryl hydrocarbon receptor by some vegetable constituents determined using in vitro reporter gene assay Biol. Pharm. Bull. 26, 532-539
101. Zhang, S., Qin, C., and Safe, S. (2003) Flavonoids as aryl hydrocarbon receptor agonists/antagonists: Effects of structure and cell context Environ. Health Perspect. 111, 1877-1882
102. Murray, I. A., Morales, J. L., Flaveny, C. A., DiNatale, B. C., Chiaro, C., Gowdahalli, K., Amin, S., and Perdew, G. H. (2010) Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity Mol. Pharmacol. 77, 247-254
103. Swedenborg, E., Rüegg, J., Hillenweck, A., Rehnmark, S., Faulds, M. H., Zalko, D., Pongratz, I., and Pettersson, K. (2008) 3-Methylcholanthrene displays dual effects on estrogen receptor (ER) α and ERβ signaling in a cell-type specific fashion Mol. Pharmacol. 73, 575-586
104. Abdelrahim, M., Smith, R., and Safe, S. (2003) Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells Mol. Pharmacol. 63, 1373-1381
105. Spink, D. C., Hayes, C. L., Young, N. R., Christou, M., Sutter, T. R., Jefcoate, C. R., and Gierthy, J. F. (1994) The effects of 2,3,7,8- tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: Evidence for induction of a novel 17[beta]-estradiol 4-hydroxylase J. Steroid Biochem. Mol. Biol. 51, 251-258
106. Spink, D. C., Lincoln, D. W., Dickerman, H. W., and Gierthy, J. F. (1990) 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17 beta-estradiol metabolism in MCF-7 breast tumor cells Proc. Natl. Acad. Sci. U. S. A. 87, 6917-6921
107. Krishnan, V., Porter, W., Santostefano, M., Wang, X., and Safe, S. (1995) Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells Mol. Cell. Biol. 15, 6710-6719
108. Ahmed, S., Valen, E., Sandelin, A., and Matthews, J. (2009) Dioxin increases the interaction between aryl hydrocarbon receptor and estrogen receptor alpha at human promoters Toxicol. Sci. 111, 254-266
109. Duan, R., Porter, W., Samudio, I., Vyhlidal, C., Kladde, M., and Safe, S. (1999) Transcriptional activation of c-fos protooncogene by 17{beta}-estradiol: Mechanism of aryl hydrocarbon receptor-mediated inhibition Mol. Endocrinol. 13, 1511-1521
110. Gillesby, B. E., Stanostefano, M., Porter, W., Safe, S., Wu, Z. F., and Zacharewski, T. R. (1997) Identification of a motif within the 5′ regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression Biochemistry (Moscow) 36, 6080-6089
111. Porter, W., Wang, F., Duan, R., Qin, C., Castro-Rivera, E., Kim, K., and Safe, S. (2001) Transcriptional activation of heat shock protein 27 gene expression by 17beta-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists J. Mol. Endocrinol. 26, 31-42
112. Kumar, M. B., Tarpey, R. W., and Perdew, G. H. (1999) Differential recruitment of coactivator RIP140 by Ah and estrogen receptors: Absence of a role for LXXLL motifs J. Biol. Chem. 274, 22155-22164
113. Beischlag, T. V., Wang, S., Rose, D. W., Torchia, J., Reisz-Porszasz, S., Muhammad, K., Nelson, W. E., Probst, M. R., Rosenfeld, M. G., and Hankinson, O. (2002) Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex Mol. Cell. Biol. 22, 4319-4333
114. Brunnberg, S., Pettersson, K., Rydin, E., Matthews, J., Hanberg, A., and Pongratz, I. (2003) The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription Proc. Natl. Acad. Sci. U.S.A. 100, 6517-6522
115. Ruegg, J., Swedenborg, E., Wahlstrom, D., Escande, A., Balaguer, P., Pettersson, K., and Pongratz, I. (2008) The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor {beta}-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin Mol. Endocrinol. 22, 304-316
116. Sanderson, J. T. (2006) The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals Toxicol. Sci. 94, 3-21
117. Miller, W. L. (1988) Molecular biology of steroid hormone synthesis Endocr. Rev. 9, 295-318
118. Ghayee, H. and Auchus, R. (2007) Basic concepts and recent developments in human steroid hormone biosynthesis Rev. Endocr. Metab. Disord. 8, 289-300
119. Nebert, D. W. and Russell, D. W. (2002) Clinical importance of the cytochromes P450 Lancet 360, 1155
120. Tsuchiya, Y., Nakajima, M., and Yokoi, T. (2005) Cytochrome P450-mediated metabolism of estrogens and its regulation in human Cancer Lett. 227, 115
121. Pinter, A., Torok, G., Borzsonyi, M., Surjan, A., Csik, M., Kelecsenyi, Z., and Kocsis, Z. (1990) Long-term carcinogenicity bioassay of the herbicide atrazine in F344 rats Neoplasma 37, 533-544
122. Wetzel, L. T., Luempert III, L. G., Breckenridge, C. B., Tisdel, M. O., Stevens, J. T., Thakur, A. K., Extrom, P. J., and Eldridge, J. C. (1994) Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague-Dawley and Fischer 344 rats J. Toxicol. Environ. Health 43, 169-182
123. Sanderson, J. T., Boerma, J., Lansbergen, G. W. A., and van den Berg, M. (2002) Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells Toxicol. Appl. Pharmacol. 182, 44-54
124. Laville, N., Balaguer, P., Brion, F., Hinfray, N., Casellas, C., Porcher, J.-M., and Aït-Aïssa, S. (2006) Modulation of aromatase activity and mRNA by various selected pesticides in the human choriocarcinoma JEG-3 cell line Toxicology 228, 98-108
125. Xu, X., Duncan, A. M., Merz, B. E., and Kurzer, M. S. (1998) Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women Cancer Epidemiol. Biomarkers Prev. 7, 1101-1108 (Pubitemid 29001666)
126. Moon, Y. J., Wang, X., and Morris, M. E. (2006) Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism Toxicol. In Vitro 20, 187-210
127. Kao, Y., Zhou, C., Sherman, M., Laughton, C., and Chen, S. (1998) Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study Environ. Health Perspect. 106, 85-92
128. van Meeuwen, J. A., Nijmeijer, S., Mutarapat, T., Ruchirawat, S., de Jong, P. C., Piersma, A. H., and van den Berg, M. (2008) Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts: A comparative study Toxicol. Appl. Pharmacol. 228, 269-276
129. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., and Sutter, T. R. (1996) 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1 Proc. Natl. Acad. Sci. U.S.A. 93, 9776-9781
130. Hammond, D. K., Zhu, B. T., Wang, M. Y., Ricci, M. J., and Liehr, J. G. (1997) Cytochrome P450 metabolism of estradiol in hamster liver and kidney Toxicol. Appl. Pharmacol. 145, 54
131. Belous, A. R., Hachey, D. L., Dawling, S., Roodi, N., and Parl, F. F. (2007) Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation Cancer Res. 67, 812-817
132. Bolton, J. L. and Thatcher, G. R. J. (2007) Potential mechanisms of estrogen quinone carcinogenesis Chem. Res. Toxicol. 21, 93-101
133. OECD (1998) Report of the First Meeting of the OECD Endocrine Disrupter Testing and Assessment (EDTA) Working Group, OECD, Paris, France.
134. EDSTAC (1998) Endocrine disruptor screening and testing advisory committee final report, 1998, U. S. Environmental Protection Agency.
135. EDSP (2009) Endocrine Disruptor Screening Program (EDSP): Announcing the Availability of the Tier 1 Screening Battery and Related Test Guidelines, pp 54415 -54422, U. S. Environmental Protection Agency.
136. Stokes, W. S. (2004) Selecting appropriate animal models and experimental designs for endocrine disruptor research and testing studies ILAR J. 45, 387-393
137. Sonneveld, E., Riteco, J. A. C., Jansen, H. J., Pieterse, B., Brouwer, A., Schoonen, W. G., and van der Burg, B. (2006) Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities Toxicol. Sci. 89, 173-187
138. Bolger, R., Wiese, T. E., Ervin, K., Nestich, S., and Checovich, W. (1998) Rapid screening of environmental chemicals for estrogen receptor binding capacity Environ. Health Perspect. 106, 551-557
139. Tamrazi, A., Carlson, K. E., Daniels, J. R., Hurth, K. M., and Katzenellenbogen, J. A. (2002) Estrogen receptor dimerization: Ligand binding regulates dimer affinity and dimer dissociation rate Mol. Endocrinol. 16, 2706-2719
140. Liu, J., Knappenberger, K. S., Kack, H., Andersson, G., Nilsson, E., Dartsch, C., and Scott, C. W. (2003) A homogeneous in vitro functional assay for estrogen receptors: Coactivator recruitment Mol. Endocrinol. 17, 346-355
141. Weatherman, R. V., Chang, C. Y., Clegg, N. J., Carroll, D. C., Day, R. N., Baxter, J. D., McDonnell, D. P., Scanlan, T. S., and Schaufele, F. (2002) Ligand-selective interactions of ER detected in living cells by fluorescence resonance energy transfer Mol. Endocrinol. 16, 487-496
142. Xu, X., Soutto, M., Xie, Q., Servick, S., Subramanian, C., von Arnim, A. G., and Johnson, C. H. (2007) Imaging protein interactions with bioluminescence resonance energy transfer (BRET) in plant and mammalian cells and tissues Proc. Natl. Acad. Sci. U.S.A. 104, 10264-10269
143. Powell, E., Huang, S.-X., Xu, Y., Rajski, S. R., Wang, Y., Peters, N., Guo, S., Eric Xu, H., Hoffmann, F. M., Shen, B., and Xu, W. (2010) Identification and characterization of a novel estrogenic ligand actinopolymorphol A Biochem. Pharmacol. 80, 1221-1229
144. Wilson, V. S., Bobseine, K., and Gray, L. E., Jr. (2004) Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists Toxicol. Sci. 81, 69-77
145. Balaguer, P., Francois, F., Comunale, F., Fenet, H., Boussioux, A., Pons, M., Nicolas, J., and Casellas, C. (1999) Reporter cell lines to study the estrogenic effects of xenoestrogens Sci. Total Environ. 233, 47-56
146. Lemaire, G., Mnif, W., Mauvais, P., Balaguer, P., and Rahmani, R. (2006) Activation of [alpha]-and [beta]-estrogen receptors by persistent pesticides in reporter cell lines Life Sci. 79, 1160-1169
147. Barkhem, T., Carlsson, B., Nilsson, Y., Enmark, E., Gustafsson, J.-Ã. k., and Nilsson, S. (1998) Differential response of estrogen receptor α and estrogen receptor β to partial estrogen
148. Li, J., Li, N., Ma, M., Giesy, J. P., and Wang, Z. (2008) In vitro profiling of the endocrine disrupting potency of organochlorine pesticides Toxicol. Lett. 183, 65-71
149. Leusch, F., de Jager, C., Levi, Y., Lim, R., Puijker, L., Sacher, F., Tremblay, L., Wilson, V., and HF, C. (2010) Comparison of five in vitro bioassays to measure estrogenic activity in environmental waters Environ. Sci. Technol. 44, 3853-3860
150. Silva, E., Scholze, M., and Kortenkamp, A. (2007) Activity of xenoestrogens at nanomolar concentrations in the E-Screen assay Environ. Health Perspect. 115, 91-97
151. Soto, A. M., Sonnenschein, C., Chung, K. L., Fernandez, M. F., Olea, N., and Serrano, F. O. (1995) The E-SCREEN Assay as a tool to identify estrogens: An update on estrogenic environmental pollutants Environ. Health Perspect. 103, 113-122
152. Zhang, X., Yu, R. M. K., Jones, P. D., Lam, G. K. W., Newsted, J. L., Gracia, T., Hecker, M., Hilscherova, K., Sanderson, J. T., Wu, R. S. S., and Giesy, J. P. (2005) Quantitative RT-PCR methods for evaluating toxicant-induced effects on steroidogenesis using the H295R cell line Environ. Sci. Technol. 39, 2777-2785
153. Letcher, R. J., van Holsteijn, I., Drenth, H.-J., Norstrom, R. J., Bergman, Å., Safe, S., Pieters, R., and van den Berg, M. (1999) Cytotoxicity and aromatase (CYP19) activity modulation by organochlorines in human placental JEG-3 and JAR choriocarcinoma cells Toxicol. Appl. Pharmacol. 160, 10-20
154. Dai, S. Y., Chalmers, M. J., Bruning, J., Bramlett, K. S., Osborne, H. E., Montrose-Rafizadeh, C., Barr, R. J., Wang, Y., Wang, M., Burris, T. P., Dodge, J. A., and Griffin, P. R. (2008) Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method Proc. Natl. Acad. Sci. U.S.A. 105, 7171-7176